This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_SMALL_INTESTINE_ADENO_EXALLC for full statistics.
Adenocarcinoma of small intestine
C3_SMALL_INTESTINE_ADENO
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
87 |
4. Check minimum number of eventsNone |
87 |
5. Include endpointsNone |
87 |
6. Filter based on genotype QC (FinnGen only) |
87 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Adenocarcinoma of small intestine
based on the number of shared cases.
Similar with more cases:
- Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of small intestine
- Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 87 | 37 | 50 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 68.91 | 65.83 | 71.18 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 83
- Matched controls
- 828
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8140/3-C17.0
ICD-O-3
Adenocarcinoma, NOS, of duodenum
+∞
42.4
37
*
130
Kela drug reimbursment
Malignant tumour
32.1
37.7
54
45
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
485.4
33.4
31
*
L01BC06
ATC
capecitabine; oral
40.4
29.6
37
16
JFB00
NOMESCO Finland
Partial resection of small intestine
45.9
25.0
30
10
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
312.9
23.9
23
*
8140/3-C17.9
ICD-O-3
Adenocarcinoma, NOS, of small intestine, NOS
+∞
23.0
21
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
294.5
22.8
22
*
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
276.6
21.7
21
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
30.0
20.3
27
13
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
86.4
18.7
20
*
A03FA01
ATC
metoclopramide; systemic, rectal
8.3
17.0
47
112
H02AB02
ATC
dexamethasone; systemic
11.5
16.9
34
47
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
195.3
16.1
16
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
34.6
15.1
19
7
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
19.6
14.0
21
14
8140/3-C17.2
ICD-O-3
Adenocarcinoma, NOS, of ileum
+∞
13.9
13
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
13.6
13.7
24
24
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
16.0
12.4
20
16
A04AA02
ATC
granisetron; systemic, transdermal
11.2
12.4
24
29
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
5.6
12.3
50
177
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
13.0
11.9
21
21
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
+∞
11.7
11
*
8140/3-C17.1
ICD-O-3
Adenocarcinoma, NOS, of jejunum
+∞
11.7
11
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
30.0
11.6
15
6
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
14.9
11.0
18
15
JAH00
NOMESCO Finland
Laparotomy
22.5
10.7
15
8
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
13.8
9.0
15
13
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.9
8.3
24
53
UJF92
NOMESCO Finland
Capsular endoscopy
37.4
8.3
10
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.7
7.9
13
11
N02AA05
ATC
oxycodone; systemic
4.6
7.8
30
91
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
6.6
7.7
20
38
JN4AD
NOMESCO Finland
Body CT examination
6.6
7.7
20
38
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
87.6
7.5
8
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
8.3
7.4
16
23
JN3AD
NOMESCO Finland
Abdominal CT examination
5.8
7.3
21
46
Z51.5
ICD-10 Finland
Palliative care
6.5
7.0
18
34
C17.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of small intestine
43.8
6.9
8
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
24.9
6.8
9
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
13.8
6.8
11
9
D64.9
ICD-10 Finland
Anaemia, unspecified
5.1
6.8
22
55
TPH07
NOMESCO Finland
Cathetrisation of artery
5.3
6.8
21
50
A04AA01
ATC
ondansetron; systemic, rectal
6.4
6.6
17
32
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000570) Elastase.pancreatic [Mass/mass] in Stool
19
21
11.30
16.17
1.6
1.5
ug/g
126.4
282.0
1.90
14
12
(40768797) Stomach Pathology biopsy report
34
102
4.83
11.00
1.7
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
64
328
4.60
9.73
8.0
3.9
—
—
—
0
0
(4035726)
27
77
4.63
9.13
1.5
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
62
332
4.02
8.35
14.4
4.9
g/l
32.1
35.2
3.74
62
314
(3023368) Bacteria identified in Blood by Culture
50
238
3.59
7.96
6.4
4.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
49
235
3.48
7.63
5.1
2.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
10
13
8.56
7.27
1.0
3.2
nmol/l
18.5
3.6
—
10
13
(3012095) Magnesium [Moles/volume] in Serum or Plasma
34
137
3.43
6.87
7.3
2.8
mmol/l
0.8
0.8
1.33
34
125
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
39
173
3.27
6.71
4.5
2.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
31
5.19
6.24
2.1
2.1
u/ml
0.3
0.3
—
9
17
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
21
68
3.75
5.81
5.9
3.3
u/l
24.4
32.1
0.95
21
59
(3032080) INR in Blood by Coagulation assay
56
326
3.01
5.73
13.4
9.1
inr
1.2
1.3
0.42
14
101
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
43
4.33
5.67
1.5
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
27
120
2.81
4.38
1.7
1.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
58
377
2.62
4.30
10.0
6.6
mmol/l
1.2
1.2
1.67
52
317
(3022145) Colonoscopy Study observation
23
97
2.86
4.08
1.7
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
31
159
2.48
3.72
1.9
1.8
nmol/l
1457.0
1152.3
0.64
25
118
(40768804) Tissue Pathology biopsy report
47
293
2.31
3.60
3.0
2.4
—
—
—
0
0
(3002256) Pathology report gross observation
21
92
2.69
3.44
1.4
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
44
3.30
3.29
1.6
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
19
84
2.61
3.04
1.6
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
29
161
2.20
2.81
1.6
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
22
110
2.34
2.71
4.0
1.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
20
4.29
2.64
1.3
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
38
241
2.02
2.57
6.3
4.1
ph
7.4
7.4
—
8
43
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
43
287
1.99
2.51
3.7
3.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
85
2.41
2.50
5.2
3.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
18
87
2.35
2.38
1.7
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
36
231
1.95
2.31
3.8
3.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
11
42
2.85
2.28
1.3
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
38
250
1.92
2.26
6.1
5.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
9
5.81
2.24
3.0
3.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
9
5.81
2.24
3.0
3.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
24
3.56
2.24
1.3
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
13
56
2.55
2.17
1.8
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
25
3.42
2.15
1.8
2.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
18
91
2.23
2.14
1.4
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
24
137
2.04
2.11
4.6
3.7
ng/l
140.6
86.9
0.22
19
116
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
44
2.72
2.10
13.5
7.9
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
5
10
5.23
2.10
4.2
7.8
mg/l
13.8
12.6
—
5
10
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
15
4.21
2.07
1.0
2.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
14
64
2.42
2.07
1.4
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
43
302
1.84
2.04
2.8
2.1
pmol/l
89.2
96.0
0.42
26
152
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
23
133
1.99
1.95
3.0
3.1
e6/l
3.9
0.9
1.03
12
72
(3030467) Casts [#/volume] in Urine by Automated count
34
225
1.84
1.93
3.9
3.4
e6/l
0.4
0.4
0.12
28
170
(40758558) Short blood count panel - Blood
30
191
1.87
1.92
16.1
7.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
37
254
1.79
1.85
3.8
3.5
e6/l
16.8
310.9
0.63
30
201
(3020891) Body temperature
8
29
2.93
1.84
8.5
4.9
—
—
—
0
0
(3012544) pH of Venous blood
15
76
2.18
1.77
6.2
5.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
11
49
2.43
1.72
3.3
4.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
19
3.31
1.69
1.2
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
47
355
1.70
1.63
5.7
5.5
e9/l
0.6
0.6
0.13
41
310
(3006315) Basophils [#/volume] in Blood
47
357
1.69
1.58
5.7
5.5
e9/l
0.0
0.0
0.81
41
313
(3013115) Eosinophils [#/volume] in Blood
48
368
1.68
1.55
5.8
5.8
e9/l
0.2
0.2
0.26
41
327
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
21
2.99
1.53
1.0
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
21
2.99
1.53
1.0
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
59
684
0.57
1.52
4.0
5.6
mmol/l
2.5
2.6
0.21
51
620
(40760892) CBC W Ordered Manual Differential panel - Blood
23
144
1.81
1.52
3.7
5.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
32
221
1.71
1.52
4.1
3.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
60
2.16
1.46
1.3
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
39
287
1.65
1.45
4.2
4.0
e6/l
1466.5
67.9
0.48
30
211
(3019198) Lymphocytes [#/volume] in Blood
47
364
1.63
1.42
5.7
5.6
e9/l
1.5
1.7
0.66
41
326
(3018677) aPTT in Platelet poor plasma by Coagulation assay
20
123
1.81
1.39
2.1
1.6
s
29.5
29.7
0.05
20
117
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
23
2.72
1.39
1.8
2.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
13
69
2.04
1.37
10.0
8.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
55
643
0.61
1.36
3.6
4.5
mmol/l
1.1
1.3
1.33
47
577
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
58
668
0.60
1.31
3.8
5.0
mmol/l
4.2
4.5
0.83
51
611
(3052851) Hemolysis interference index of Serum or Plasma
6
26
2.40
1.21
3.8
3.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
16
96
1.82
1.20
1.4
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
20
129
1.71
1.19
3.1
3.3
e6/l
3.0
2.3
—
9
69
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
8
39
2.16
1.19
5.0
3.1
%
0.6
0.7
—
8
39
(3019060) Gas panel - Arterial blood
11
58
2.03
1.18
10.3
4.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
58
662
0.63
1.15
3.7
5.0
mmol/l
1.3
1.4
2.29
51
597
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
41
2.05
1.12
5.0
3.1
%
0.9
1.1
—
8
41
(3045414) Leukocytes [Presence] in Urine
5
21
2.46
1.10
2.2
2.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
9
48
1.97
1.04
7.0
5.1
mmol/l
23.2
24.8
—
9
48
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
54
619
0.66
1.00
5.1
4.8
mu/l
2.0
2.0
0.06
49
547
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
28
0.00
0.99
0.0
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
52
1.81
0.96
1.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
16
229
0.63
0.86
3.0
3.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
8
46
1.81
0.85
1.3
3.5
e6/l
1.5
0.1
—
8
46
(3049717) Cytology report of Urine Cyto stain
6
32
1.94
0.83
5.2
3.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
33
1.88
0.80
1.0
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
39
319
1.40
0.78
24.8
10.4
e9/l
0.0
0.0
0.49
32
261
(3000330) Specific gravity of Urine by Test strip
7
40
1.81
0.73
10.1
4.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
42
351
1.38
0.73
9.2
5.5
estimate
0.0
0.0
—
10
67
(42529406) Shigella sp [Presence] in Stool by Culture
5
26
1.98
0.72
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
26
1.98
0.72
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
26
1.98
0.72
1.0
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
25
313
0.72
0.66
4.6
5.3
ug/l
1.8
2.1
0.25
18
273
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
21
0.00
0.61
0.0
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
81
1.56
0.61
15.7
8.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
42
359
1.33
0.60
6.4
4.0
estimate
0.0
0.0
—
9
64
(3019225) pH of Specimen
11
74
1.56
0.56
2.7
4.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
22
172
1.37
0.55
2.2
1.9
pmol/l
378.2
436.4
0.65
16
143
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
19
242
0.73
0.54
3.9
4.7
%
24.2
21.9
—
8
111
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
39
334
1.30
0.54
2.6
2.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
41
358
1.27
0.47
6.6
3.9
estimate
0.0
0.0
—
10
68
(3020682) Albumin/Creatinine [Ratio] in Urine
21
256
0.76
0.44
4.5
4.0
mg/mmol
19.5
8.2
0.34
15
158
(3012516) Albumin [Mass/volume] in Urine
20
244
0.77
0.42
3.4
3.1
mg/l
103.7
301.6
0.35
14
161
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
5
33
1.55
0.42
1.0
1.1
—
94.6
—
0
6
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
16
0.00
0.41
0.0
3.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
64
680
0.78
0.40
4.4
5.1
mmol/l
6.1
6.1
0.07
59
619
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
53.8
—
0
18
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.3
—
2.1
—
0
5
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
68
1.36
0.39
1.3
1.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
68
715
0.78
0.36
57.4
20.8
umol/l
79.2
83.9
0.39
68
715
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
43
1.42
0.36
1.3
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
62
658
0.80
0.36
46.0
16.6
ml/min/173m2
78.5
73.7
0.91
57
544
(3037467) Urinalysis macro (dipstick) panel - Urine
54
499
1.22
0.33
7.5
4.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
23
195
1.24
0.33
6.0
4.1
estimate
0.0
0.0
—
10
61
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
13
102
1.32
0.32
2.0
3.9
u/l
211.4
241.9
0.97
13
97
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
10
76
1.36
0.29
1.8
2.1
ug/l
5.8
6.1
—
10
67
(3022621) pH of Urine by Test strip
8
62
1.32
0.29
2.6
2.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
16
132
1.26
0.28
1.4
1.3
g/l
2.7
3.0
—
10
78
(40761536) Microorganisms panel - Urine sediment
8
65
1.25
0.28
5.5
3.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
19
164
1.20
0.23
5.1
3.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
14.4
—
0
10
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
12
0.00
0.21
0.0
1.4
—
150.0
—
0
12
(40768806) Pleura Pathology biopsy report
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
13
0.00
0.21
0.0
3.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
13
0.00
0.21
0.0
3.2
—
—
—
0
0
(3044889) 12 lead EKG panel
53
501
1.15
0.20
6.1
4.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
49
1.24
0.20
1.5
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
35
323
1.14
0.19
4.9
4.4
ng/l
21.9
47.7
2.13
26
246
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
30
276
1.13
0.16
7.9
4.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
22
203
1.11
0.11
7.4
3.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
56
1.08
0.09
1.0
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
5
61
0.81
0.08
1.8
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
51
495
1.07
0.07
4.2
3.9
pmol/l
14.9
14.9
0.10
45
434
(3013707) Erythrocyte sedimentation rate by Westergren method
55
536
1.07
0.07
4.5
4.5
mm/h
22.3
14.2
1.64
49
486
(40761511) CBC panel - Blood by Automated count
68
689
0.94
0.03
49.6
16.1
—
—
—
0
0
(3013512) EKG study
23
238
0.95
0.02
5.7
4.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
18
182
0.99
0.00
2.3
3.0
ug/l
0.9
0.7
—
9
125
(3009542) Hematocrit [Volume Fraction] of Blood
58
582
0.99
0.00
48.1
18.4
%
33.8
39.5
2.80
33
401
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
5
52
0.96
0.00
4.6
3.2
kpa
5.2
5.0
—
5
46
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
45.8
—
0
5
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
37.1
—
0
9
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
19.3
—
0
5
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
18.4
—
0
6
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.4
—
11.8
—
0
9
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
7
0.00
0.00
0.0
2.7
—
11.0
—
0
7
(46235355) HIV 1 and 2 tests - Meaningful Use set
8
83
0.96
0.00
1.4
1.6
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
6
0.00
0.00
0.0
2.3
—
3.9
—
0
6
(3002523) Influenza virus A Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
13.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_SMALL_INTESTINE_ADENO – Adenocarcinoma of small intestine
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).